We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Avanir Responds to FDA’s Zenvia Approvable Letter
Avanir Responds to FDA’s Zenvia Approvable Letter
April 30, 2010
Avanir Pharmaceuticals has submitted a complete response to a 2006 approvable letter for pseudobulbar affect (PBA) drug Zenvia and could see a decision
by the end of the year.